Access to Ossium HPC, Marrow for the Treatment of Hematologic Diseases

Full Title

A Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for HOPE Patients with Hematologic Malignancies or Disorders (EAP)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Brian Shaffer’s office at 646-608-3737.